Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Mereo BioPharma

- PMLiVE

Celgene’s Revlimid wins US lymphoma approval

FDA recommends extra indication for blockbuster cancer drug

- PMLiVE

EMA backs Pomalidomide Celgene in multiple myeloma

Further positive CHMP opinions for new medicines form Aegerion, Teva and more

- PMLiVE

Celgene promotes Karen Browne to haematology director

She takes up a new role with the company's UK and Ireland business

- PMLiVE

Celgene’s apremilast set for 2013 filing

Pharma company releases positive phase III results for psoriasis candidate

- PMLiVE

Celgene gets US green light for blockbuster candidate Pomalyst

FDA approval to treat multiple myeloma

- PMLiVE

Sarah Bater joins Celgene

Will head human resources in UK and Ireland

- PMLiVE

Celgene signs $500m antibody deal with Sutro

Joins list of companies with interest in antibody-drug conjugates

- PMLiVE

Celgene wins 2012 PMEA for excellence in ongoing brand management

Also receives recognition for internal capability development and orphan drug Vidaza

Celgene’s Abraxane receives FDA approval in lung cancer

Adds to current breast cancer indication

- PMLiVE

Interview: Sam Pearce, Celgene

The general manager of Celgene UK and Ireland explains to Liz Wells how her entrepreneurial spirit fits well with this fast-expanding biotech

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links